Immuno Oncology Assays Market Size, Trends, Analysis, and Outlook By Products and Services (Consumables, Instruments, Software & Services), By Technology (PCR, Immunoassay, NGS, ISH, Flow Cytometry), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Melanoma, Others), By Application (Research Applications, Clinical Diagnostics), by Country, Segment, and Companies, 2024-2032
The global Immuno Oncology Assays market size is poised to register 11.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Immuno Oncology Assays market across By Products and Services (Consumables, Instruments, Software & Services), By Technology (PCR, Immunoassay, NGS, ISH, Flow Cytometry), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Melanoma, Others), By Application (Research Applications, Clinical Diagnostics)
The immuno-oncology assays market is characterized by the increasing focus on cancer immunotherapy and immune checkpoint inhibitors, advancements in biomarker detection and immune profiling technologies, and the growing need for companion diagnostics and patient stratification strategies. By 2030, the market is poised to witness steady growth, driven by innovations in immune cell profiling, cytokine analysis, and immune response monitoring. Further, expanding applications in cancer immunotherapy trials, biomarker discovery, and treatment monitoring are expected to drive market expansion, enabling biopharmaceutical companies, clinical laboratories, and research institutions to assess immune function, predict treatment responses, and develop personalized immunotherapies through immuno-oncology assays that offer sensitivity, specificity, and multiplexing capabilities for immune monitoring and cancer immunology research in the immuno-oncology market and precision oncology field.
Immuno Oncology Assays Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Immuno Oncology Assays market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Immuno Oncology Assays survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Immuno Oncology Assays industry.
Key market trends defining the global Immuno Oncology Assays demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Immuno Oncology Assays Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Immuno Oncology Assays industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Immuno Oncology Assays companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Immuno Oncology Assays industry
Leading Immuno Oncology Assays companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Immuno Oncology Assays companies.
Immuno Oncology Assays Market Study- Strategic Analysis Review
The Immuno Oncology Assays market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Immuno Oncology Assays industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Immuno Oncology Assays Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Immuno Oncology Assays Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Immuno Oncology Assays market segments. Similarly, Strong market demand is encouraging Canadian Immuno Oncology Assays companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Immuno Oncology Assays market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Immuno Oncology Assays Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Immuno Oncology Assays industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Immuno Oncology Assays market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Immuno Oncology Assays Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Immuno Oncology Assays in Asia Pacific. In particular, China, India, and South East Asian Immuno Oncology Assays markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Immuno Oncology Assays Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Immuno Oncology Assays Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Immuno Oncology Assays market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Immuno Oncology Assays.
Immuno Oncology Assays Market Company Profiles
The global Immuno Oncology Assays market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories Inc, Agilent Technologies Inc, ASURAGEN Inc, bioMйrieux SA, Bio-Rad Laboratories Inc, Charles River Laboratories Inc, Creative Biolabs, F. Hoffmann-La Roche Ltd, Guardant Health Inc, HTG Molecular Diagnostics Inc, Illumina Inc, Invivoscribe Inc, Merck Millipore, Meso Scale Diagnostics Llc, Myriad Genetics Inc, NanoString Technologies Inc, NMI Technologietransfer GmbH, PerkinElmer Inc, Qiagen N.V., ReachBio LLC , Sartorius AG, Seegene Inc, Thermo Fisher Scientific Inc.
Recent Immuno Oncology Assays Market Developments
The global Immuno Oncology Assays market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Immuno Oncology Assays Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Products and Services
Consumables
Instruments
Software & Services
By Technology
PCR
Immunoassay
NGS
ISH
Flow Cytometry
By Indication
Lung Cancer
Breast Cancer
Colorectal Cancer
Bladder Cancer
Melanoma
Others
By Application
Research Applications
Clinical Diagnostics
Geographical Segmentation:
Abbott Laboratories Inc
Agilent Technologies Inc
ASURAGEN Inc
bioMйrieux SA
Bio-Rad Laboratories Inc
Charles River Laboratories Inc
Creative Biolabs
F. Hoffmann-La Roche Ltd
Guardant Health Inc
HTG Molecular Diagnostics Inc
Illumina Inc
Invivoscribe Inc
Merck Millipore
Meso Scale Diagnostics Llc
Myriad Genetics Inc
NanoString Technologies Inc
NMI Technologietransfer GmbH
PerkinElmer Inc
Qiagen N.V.
ReachBio LLC
Sartorius AG
Seegene Inc
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The immuno-oncology assays market is characterized by the increasing focus on cancer immunotherapy and immune checkpoint inhibitors, advancements in biomarker detection and immune profiling technologies, and the growing need for companion diagnostics and patient stratification strategies. By 2030, the market is poised to witness steady growth, driven by innovations in immune cell profiling, cytokine analysis, and immune response monitoring. Further, expanding applications in cancer immunotherapy trials, biomarker discovery, and treatment monitoring are expected to drive market expansion, enabling biopharmaceutical companies, clinical laboratories, and research institutions to assess immune function, predict treatment responses, and develop personalized immunotherapies through immuno-oncology assays that offer sensitivity, specificity, and multiplexing capabilities for immune monitoring and cancer immunology research in the immuno-oncology market and precision oncology field.
Immuno Oncology Assays Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Immuno Oncology Assays market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Immuno Oncology Assays survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Immuno Oncology Assays industry.
Key market trends defining the global Immuno Oncology Assays demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Immuno Oncology Assays Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Immuno Oncology Assays industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Immuno Oncology Assays companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Immuno Oncology Assays industry
Leading Immuno Oncology Assays companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Immuno Oncology Assays companies.
Immuno Oncology Assays Market Study- Strategic Analysis Review
The Immuno Oncology Assays market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Immuno Oncology Assays industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Immuno Oncology Assays Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Immuno Oncology Assays Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Immuno Oncology Assays market segments. Similarly, Strong market demand is encouraging Canadian Immuno Oncology Assays companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Immuno Oncology Assays market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Immuno Oncology Assays Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Immuno Oncology Assays industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Immuno Oncology Assays market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Immuno Oncology Assays Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Immuno Oncology Assays in Asia Pacific. In particular, China, India, and South East Asian Immuno Oncology Assays markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Immuno Oncology Assays Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Immuno Oncology Assays Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Immuno Oncology Assays market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Immuno Oncology Assays.
Immuno Oncology Assays Market Company Profiles
The global Immuno Oncology Assays market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories Inc, Agilent Technologies Inc, ASURAGEN Inc, bioMйrieux SA, Bio-Rad Laboratories Inc, Charles River Laboratories Inc, Creative Biolabs, F. Hoffmann-La Roche Ltd, Guardant Health Inc, HTG Molecular Diagnostics Inc, Illumina Inc, Invivoscribe Inc, Merck Millipore, Meso Scale Diagnostics Llc, Myriad Genetics Inc, NanoString Technologies Inc, NMI Technologietransfer GmbH, PerkinElmer Inc, Qiagen N.V., ReachBio LLC , Sartorius AG, Seegene Inc, Thermo Fisher Scientific Inc.
Recent Immuno Oncology Assays Market Developments
The global Immuno Oncology Assays market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Immuno Oncology Assays Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Products and Services
Consumables
Instruments
Software & Services
By Technology
PCR
Immunoassay
NGS
ISH
Flow Cytometry
By Indication
Lung Cancer
Breast Cancer
Colorectal Cancer
Bladder Cancer
Melanoma
Others
By Application
Research Applications
Clinical Diagnostics
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories Inc
Agilent Technologies Inc
ASURAGEN Inc
bioMйrieux SA
Bio-Rad Laboratories Inc
Charles River Laboratories Inc
Creative Biolabs
F. Hoffmann-La Roche Ltd
Guardant Health Inc
HTG Molecular Diagnostics Inc
Illumina Inc
Invivoscribe Inc
Merck Millipore
Meso Scale Diagnostics Llc
Myriad Genetics Inc
NanoString Technologies Inc
NMI Technologietransfer GmbH
PerkinElmer Inc
Qiagen N.V.
ReachBio LLC
Sartorius AG
Seegene Inc
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Immuno Oncology Assays Market Overview and Key Findings, 2024
1.2 Immuno Oncology Assays Market Size and Growth Outlook, 2021- 2030
1.3 Immuno Oncology Assays Market Growth Opportunities to 2030
1.4 Key Immuno Oncology Assays Market Trends and Challenges
1.4.1 Immuno Oncology Assays Market Drivers and Trends
1.4.2 Immuno Oncology Assays Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Immuno Oncology Assays Companies
2. IMMUNO ONCOLOGY ASSAYS MARKET SIZE OUTLOOK TO 2030
2.1 Immuno Oncology Assays Market Size Outlook, USD Million, 2021- 2030
2.2 Immuno Oncology Assays Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IMMUNO ONCOLOGY ASSAYS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IMMUNO ONCOLOGY ASSAYS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Consumables
Instruments
Software & Services
By Technology
PCR
Immunoassay
NGS
ISH
Flow Cytometry
By Indication
Lung Cancer
Breast Cancer
Colorectal Cancer
Bladder Cancer
Melanoma
Others
By Application
Research Applications
Clinical Diagnostics
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Immuno Oncology Assays Market, 2025
5.2 Asia Pacific Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Immuno Oncology Assays Market, 2025
5.5 Europe Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.6 Europe Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Immuno Oncology Assays Market, 2025
5.8 North America Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.9 North America Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Immuno Oncology Assays Market, 2025
5.11 South America Pacific Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.12 South America Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Immuno Oncology Assays Market, 2025
5.14 Middle East Africa Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Immuno Oncology Assays Market Size Outlook and Revenue Growth Forecasts
6.2 US Immuno Oncology Assays Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Immuno Oncology Assays Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Immuno Oncology Assays Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Immuno Oncology Assays Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Immuno Oncology Assays Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Immuno Oncology Assays Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Immuno Oncology Assays Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Immuno Oncology Assays Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Immuno Oncology Assays Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Immuno Oncology Assays Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Immuno Oncology Assays Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Immuno Oncology Assays Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Immuno Oncology Assays Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Immuno Oncology Assays Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Immuno Oncology Assays Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Immuno Oncology Assays Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Immuno Oncology Assays Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Immuno Oncology Assays Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Immuno Oncology Assays Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Immuno Oncology Assays Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Immuno Oncology Assays Industry Drivers and Opportunities
7. IMMUNO ONCOLOGY ASSAYS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IMMUNO ONCOLOGY ASSAYS COMPANY PROFILES
8.1 Profiles of Leading Immuno Oncology Assays Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories Inc
Agilent Technologies Inc
ASURAGEN Inc
bioMйrieux SA
Bio-Rad Laboratories Inc
Charles River Laboratories Inc
Creative Biolabs
F. Hoffmann-La Roche Ltd
Guardant Health Inc
HTG Molecular Diagnostics Inc
Illumina Inc
Invivoscribe Inc
Merck Millipore
Meso Scale Diagnostics Llc
Myriad Genetics Inc
NanoString Technologies Inc
NMI Technologietransfer GmbH
PerkinElmer Inc
Qiagen N.V.
ReachBio LLC
Sartorius AG
Seegene Inc
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Immuno Oncology Assays Market Overview and Key Findings, 2024
1.2 Immuno Oncology Assays Market Size and Growth Outlook, 2021- 2030
1.3 Immuno Oncology Assays Market Growth Opportunities to 2030
1.4 Key Immuno Oncology Assays Market Trends and Challenges
1.4.1 Immuno Oncology Assays Market Drivers and Trends
1.4.2 Immuno Oncology Assays Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Immuno Oncology Assays Companies
2. IMMUNO ONCOLOGY ASSAYS MARKET SIZE OUTLOOK TO 2030
2.1 Immuno Oncology Assays Market Size Outlook, USD Million, 2021- 2030
2.2 Immuno Oncology Assays Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IMMUNO ONCOLOGY ASSAYS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IMMUNO ONCOLOGY ASSAYS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Consumables
Instruments
Software & Services
By Technology
PCR
Immunoassay
NGS
ISH
Flow Cytometry
By Indication
Lung Cancer
Breast Cancer
Colorectal Cancer
Bladder Cancer
Melanoma
Others
By Application
Research Applications
Clinical Diagnostics
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Immuno Oncology Assays Market, 2025
5.2 Asia Pacific Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Immuno Oncology Assays Market, 2025
5.5 Europe Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.6 Europe Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Immuno Oncology Assays Market, 2025
5.8 North America Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.9 North America Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Immuno Oncology Assays Market, 2025
5.11 South America Pacific Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.12 South America Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Immuno Oncology Assays Market, 2025
5.14 Middle East Africa Immuno Oncology Assays Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Immuno Oncology Assays Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Immuno Oncology Assays Market Size Outlook and Revenue Growth Forecasts
6.2 US Immuno Oncology Assays Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Immuno Oncology Assays Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Immuno Oncology Assays Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Immuno Oncology Assays Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Immuno Oncology Assays Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Immuno Oncology Assays Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Immuno Oncology Assays Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Immuno Oncology Assays Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Immuno Oncology Assays Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Immuno Oncology Assays Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Immuno Oncology Assays Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Immuno Oncology Assays Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Immuno Oncology Assays Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Immuno Oncology Assays Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Immuno Oncology Assays Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Immuno Oncology Assays Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Immuno Oncology Assays Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Immuno Oncology Assays Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Immuno Oncology Assays Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Immuno Oncology Assays Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Immuno Oncology Assays Industry Drivers and Opportunities
7. IMMUNO ONCOLOGY ASSAYS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IMMUNO ONCOLOGY ASSAYS COMPANY PROFILES
8.1 Profiles of Leading Immuno Oncology Assays Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories Inc
Agilent Technologies Inc
ASURAGEN Inc
bioMйrieux SA
Bio-Rad Laboratories Inc
Charles River Laboratories Inc
Creative Biolabs
F. Hoffmann-La Roche Ltd
Guardant Health Inc
HTG Molecular Diagnostics Inc
Illumina Inc
Invivoscribe Inc
Merck Millipore
Meso Scale Diagnostics Llc
Myriad Genetics Inc
NanoString Technologies Inc
NMI Technologietransfer GmbH
PerkinElmer Inc
Qiagen N.V.
ReachBio LLC
Sartorius AG
Seegene Inc
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
